AngioDynamics (NASDAQ:ANGO) Announces Quarterly Earnings Results

Share on StockTwits

AngioDynamics (NASDAQ:ANGO) released its earnings results on Wednesday. The medical instruments supplier reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.03, MarketWatch Earnings reports. The company had revenue of $72.80 million for the quarter, compared to the consensus estimate of $67.33 million. AngioDynamics had a negative net margin of 62.90% and a positive return on equity of 0.18%. AngioDynamics’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.06 EPS.

NASDAQ ANGO traded up $0.23 on Friday, hitting $18.80. 8,777 shares of the company’s stock traded hands, compared to its average volume of 240,508. The company has a current ratio of 3.57, a quick ratio of 2.25 and a debt-to-equity ratio of 0.09. AngioDynamics has a 1-year low of $7.48 and a 1-year high of $19.52. The firm’s 50-day moving average price is $14.29 and its two-hundred day moving average price is $11.16. The firm has a market capitalization of $713.46 million, a PE ratio of -4.18 and a beta of 0.89.

Several analysts have weighed in on the stock. Zacks Investment Research downgraded shares of AngioDynamics from a “buy” rating to a “hold” rating and set a $15.00 target price on the stock. in a research report on Tuesday, December 1st. Canaccord Genuity boosted their target price on shares of AngioDynamics from $14.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday. BidaskClub raised shares of AngioDynamics from a “hold” rating to a “buy” rating in a research report on Wednesday. Finally, Raymond James lifted their price objective on shares of AngioDynamics from $18.00 to $24.00 and gave the company a “strong-buy” rating in a research note on Friday. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. AngioDynamics has a consensus rating of “Buy” and an average target price of $19.00.

About AngioDynamics

AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.

See Also: What is total return in investing?

Earnings History for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with's FREE daily email newsletter.